Research programme: sublingual spray therapeutics - INSYS Therapeutics

Drug Profile

Research programme: sublingual spray therapeutics - INSYS Therapeutics

Alternative Names: Diclofenac sublingual spray - INSYS; Ketorolac sublingual spray - INSYS; Sildenafil sublingual spray - INSYS; Supportive care sublingual spray - INSYS

Latest Information Update: 18 Oct 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator INSYS Therapeutics, Inc
  • Class 2 ring heterocyclic compounds; Carbazoles; Cyclopropanes; Imidazoles; Morphinans; Non-opioid analgesics; Opioid analgesics; Phenyl ethers; Phenylacetates; Piperazines; Purines; Small molecules; Sulfones
  • Mechanism of Action Cyclo-oxygenase 1 inhibitors; Cyclo-oxygenase 2 inhibitors; Cyclooxygenase inhibitors; Nociceptin receptor agonists; Opioid delta receptor antagonists; Opioid kappa receptor antagonists; Type 5 cyclic nucleotide phosphodiesterase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Erectile dysfunction; Musculoskeletal pain; Pain

Most Recent Events

  • 29 Feb 2016 Preclinical development of Diclofenac, Ketorolac, and Sildenafil sublingual sprays is ongoing in USA (INSYS Therapeutics Form 10-K, February 2016)
  • 01 Jan 2014 Preclinical trials in Erectile dysfunction in USA (Sublingual)
  • 01 Jan 2014 Preclinical trials in Musculoskeletal pain in USA (Sublingual)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top